Published in AIDS Weekly, October 19th, 2009
"Members include representatives of governmental agencies, the pharmaceutical and diagnostic industries, foundations, and payers; community advocates; and members of academia. This unique model incorporates the perspectives of each of its member constituencies," wrote V. Miller and colleagues.
The researchers concluded: "The benefits of this model include reducing uncertainty and accelerating the flow of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.